材料与化学化工学部学术报告:Nanoparticles for Drug Targeting: Past, Present and Future

报告题目: Nanoparticles for Drug Targeting: Past, Present and Future

: Prof. Gert Storm

1Dept. Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands ; 2 Dept. Biomaterials Science & Technology (BST), MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands

报告时间: 2019319星期二上午10:30-11:30

报告地点: 独墅湖校区911号楼401

 

报告摘要: One most active sector of research within the field of nanomedicine has been the design of nanoparticulate pharmaceuticals for targeted drug delivery. In fact, novel and established nanoparticle systems continue to flourish in the research laboratory.  However, the number of such systems that have been approved for the treatment of patients is still limited. Examples are Caelyx/Doxil (doxorubicin), Myocet (doxorubicin), DaunoXome (daunorubicin), Marqibo (vincristine), Onyvide (irinotecan), Onco-TCS (vincristine), Vyxeos (cytarabine and daunorubicin), Abraxane (paclitaxel) and Onpattro (transthyretin-directed siRNA). While these examples illustrate that significant advances have been made over the years in making nanoparticulate nanomedicines a clinical reality, there is nevertheless growing sceptism in the scientific literature regarding the future and clinical applicability of such targeted nanopharmaceuticals. In this presentation, I will discuss the arguments raised to justify this negative attitude as well as my different view on the current status and future of the use of nanoparticles for drug targeting.

 

报告人简介:Gert Storm, professor (Targeted Drug Delivery) at the Department of Pharmaceutics (80% employment), obtained his Ph.D. degree in 1987 at the Utrecht University. In 1988-1989, he was a visiting scientist at Liposome Technology Inc. in Menlo Park, USA, and visiting assistant professor at the School of Pharmacy, UCSF, San Francisco. In 1990-1991, he became senior research scientist at Pharma Bio-Research Consultancy B.V. in Zuidlaren, The Netherlands. During this period he contributed to the design, co-ordination and evaluation of clinical pharmacological studies. In September 1991 he took up his position at the Utrecht University. He is honorary professor (Biomacromolecular Drug Delivery) at the University of Copenhagen. From 2012 on, he is also professor (Targeted Therapeutics) at the MIRA institute of the University of Twente (20% employment). Furthermore, he keeps a position (seconded) at the University Medical Center Utrecht (UMCU) (Division Imaging).

To date, he has co-authored more than 540 publications (h-index >90). The design, characterization and (pre)clinical testing of targeted nanomedicine formulations is the core activity. Additionally, the implementation of imaging-guided drug delivery protocols (using e.g. SPECT, MRI, PET) is a major research objective.

From 2014 on, he is every year included in the lists of The World’s Most Influential Scientific Minds of Thomson Reuters (Highly Cited Researchers) and more recently Clarivate Analytics.

Over the last decade, clinical translation of academic results has become a vital element of Prof. Storm’s ambition, as exemplified by the clinical development of liposomal corticosteroids (by the creation of the spin-off company Enceladus Pharmaceuticals BV in 2005), the clinical breast cancer study at the UMCU evaluating image-guided targeted doxorubicin delivery with hyperthermia (follow-up of the HIFU-CHEM project), his involvement in public-private partnership projects, i.e. EC (coordinator Meditrans (FP6), partnering in 4 FP7 projects and 2 Horizon2020 projects), CTMM (PI HIFU-CHEM), NanoNextNL (director Program Drug Delivery), TI-Pharma and AgentschapNL. Over the years, he also obtained significant funding for applied research from STW and several large industries (e.g. Astellas, Astra Zeneca, Novartis). He is on the Board of the CLINAM (European Foundation for Clinical Nanomedicine) organization in Basel, and the PRC (Phospholipid Research Center) in Heidelberg.

(材料与化学化工学部)
苏大概况 教育教学
院部设置 科学研究
组织机构 合作交流
招生就业 公共服务
Copyright 澳门太阳城娱乐场 2016, All Rights Reserved

苏州市十梓街1号 组织策划:校长办公室

苏ICP备-10229414  苏公网安备 32050802010530号
推荐使用IE8.0以上浏览器,1280*760分辨率访问本网
友情链接:mg老虎机  mg电子游艺  mg电子游戏摆脱破解  mg电子游戏摆脱  mg电子游戏破解  太阳城娱乐城  太阳城娱乐场  365bet足球比分  众博棋牌网址  众博棋牌下载  众博棋牌官网  葡京娱乐网址  葡京娱乐官网  葡京娱乐网站  mg电子  mg游戏  冠通棋牌网址  澳门永利线上娱乐场  澳门凯旋门注册网址  九乐棋牌  拉斯维加斯网站  澳门太阳城娱乐场  威尼斯人娱乐场注册  澳门威尼斯人娱乐场网址  澳门威尼斯人娱乐平台  北京PK10开奖直播  北京赛车pk10开奖结果  澳门金沙娱乐平台  银河娱乐场官网  银河娱乐场网址  银河娱乐场  冠通棋牌下载  冠通棋牌官网  澳门金沙赌场网址  澳门金沙赌场平台  澳门金沙赌场网站  威尼斯人娱乐场网站  金沙娱乐网址  澳门银河网上娱乐场  澳门银河网上娱乐  美高梅开户网站  赌场注册  365bet在线体育  澳门巴黎人真正开户网址  澳门海立方开户网站  澳门新葡京娱乐场网址  澳门赌场网站官网  澳门赌场网站平台  新世界棋牌网址  新世界棋牌下载  新世界棋牌官网  澳门赌场开户网址  澳门赌场注册平台  老葡京注册  澳门娱乐赌场官网  老葡京开户  澳门金沙赌场网址   新金沙注册开户网址  新金沙开户  澳门威尼斯人娱乐  澳门新葡京娱乐场官网  新金沙游戏平台  新金沙网址平台  捕鱼游戏破解  澳门金沙线上官网  澳门威尼斯人官网址  澳门金沙网站【wnsr88.com】  mg电子游戏注册  mg电子游戏开户  澳门新濠天地赌场开户网站   澳门新濠天地赌场开户网站  澳门娱乐赌场网址  澳门娱乐赌场网站  澳门银河注册平台   澳门葡京赌场注册   澳门老葡京开户网址  澳门老葡京注册官网   澳门银河注册网站   hr娱乐平台下载  hr娱乐平台  hr娱乐平台可以吗   威尼斯人开户网站  威尼斯人注册   威尼斯人网上娱乐场  威尼斯人娱乐场官网   威尼斯人娱乐场官网  九五至尊网站   九五至尊网站  现金博彩  澳门新濠天地开户官网  澳门银河场网址  金沙网上娱乐  澳门葡京赌场官网网址  威尼斯人线上娱乐城  威尼斯人娱乐场开户  威尼斯人网址网站官网  天天时时彩五星计划  天天时时彩五星计划  光明棋牌下载  光明棋牌官网